Stock listing

OTC:AOLS Aeolus Pharmaceuticals Inc Stock

Follow Aeolus Pharmaceuticals Inc into a list and get an email when it puts out news.

Share price · OTC:AOLS

$0.0001 USD 0.0000 (0.0%)

Close on Nov 19, 2026 · Data provided by Twelve Data

Past year 0.0% · daily closes, Nov 19, 2025 – Nov 19, 2026, adjusted for splits
Day range
$0.0001 – $0.0001 USDNov 19, 2026
Market cap
—Left out: price × shares is far from the company's reported size
52-week range
$0.0001 – $0.0001 USDLowest and highest trades, Nov 20, 2025 – Nov 19, 2026
Traded on an average day
$0 USDMedian day 0 shares · 66 days with no trades · last 3 months, Aug 19, 2026 – Nov 19, 2026
Aeolus Pharmaceuticals Inc logo

Daily closes

Last 3 months, Aug 19, 2026 – Nov 19, 2026 · OTC:AOLS · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
Ticker
OTC:AOLS
Asset type
Stock
Exchange
OTC
Currency
USD

Latest news

All Aeolus Pharmaceuticals Inc news

Aeolus Pharmaceuticals Inc on 6ix

News releases
32 in all · newest Mar 23, 2018 · oldest 2015
Decks
2 decks · latest January 2013

Valuation

price Nov 19, 2026

Enterprise value
No market cap
P/E
No market cap
EV/sales
No market cap
EV/EBITDA
No market cap
Price/book
No market cap
Gross margin
No statements on 6ix yet
Operating margin
No statements on 6ix yet
Net margin
No statements on 6ix yet
Debt to equity
No statements on 6ix yet
Beta vs S&P 500
0.00

Team and board

Officers

OfficerRole
John L. McManusChief Executive Officer
Russell SkibstedChief Financial Officer
Christopher StanleyVP, Operations
Brian DayChief Scientific Officer

Board

DirectorRole
David C. CavalierChairman
Amit KumarBoard Member
Chris A. RallisBoard Member
Jeffrey A. ScottBoard Member
John M. ClericiBoard Member
John M. FarahBoard Member
Mitchell D. KayeBoard Member

Decks

DeckKindSlidesDate
Investor Presentation (January 2013)Investor deck31 slidesJanuary 2013
Investor Presentation (November 2004)Investor deck34 slidesNov 16, 2004

Open Decks

Cap table

Built by 6ix from Aeolus Pharmaceuticals Inc’s releases

Common shares
152,085,825
Fully diluted
152,085,825

Fully diluted

LineShares
Common shares152,085,825

Share count over time

CountShares
Nov 22, 2026152,085,825

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Russell Skibsted
Other companies: Processa Pharmaceuticals, Inc. (Chief Financial Officer · Since at least Jul 16, 2024); Alimera Sciences Inc (Chief Financial Officer & SVP · Jan 9, 2023 – Nov 21, 2023 · Past); Rockwell Medical, Inc. (See Remarks · Sep 15, 2020 – Sep 9, 2022 · Past); Serina Therapeutics, Inc. (Chief Financial Officer · Nov 27, 2018 – Dec 31, 2018 · Past); Insight Molecular Diagnostics Inc. (Chief Financial Officer · Dec 30, 2015 – Dec 30, 2015 · Past); Lineage Cell Therapeutics, Inc. (Chief Financial Officer · Nov 16, 2015 – Dec 18, 2018 · Past)
Chief Financial Officer · Since at least May 23, 2012
Chris A. Rallis
Other companies: Fennec Pharmaceuticals Inc. (Director · Since at least Sep 11, 2017); Tenax Therapeutics, Inc. (Director · Dec 16, 2011 – Jun 15, 2020 · Past)
Board Member · Since at least Sep 12, 2006
Amit Kumar
Other companies: Anixa Biosciences, Inc. (Chief Executive Officer, Director · Since at least May 8, 2018)
Board Member · Since at least Nov 14, 2026
David C. Cavalier
Other companies: Anixa Biosciences, Inc. (Director · Sep 27, 2018 – Aug 13, 2020 · Past)
Chairman · Since at least Jul 27, 2007
Joseph J Krivulka
Other companies: Nektar Therapeutics (Director · Sep 19, 2013 – Sep 19, 2017 · Past)
Director · May 8, 2013 – May 8, 2013 · Past
Brian DayChief Scientific Officer · Since at least Nov 14, 2026
Christopher StanleyVP, Operations · Since at least Nov 14, 2026
Jeffrey A. ScottBoard Member · Since at least Nov 14, 2026
John L. McManusChief Executive Officer · Since at least Dec 30, 2005
John M. ClericiBoard Member · Since at least Nov 14, 2026
All 12 people
PersonSeat
John M. FarahBoard Member · Since at least Nov 14, 2026
Mitchell D. KayeBoard Member · Since at least Nov 14, 2026

Open People

Log in to ask 6ix AI your own questions about Aeolus Pharmaceuticals Inc.